Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix vs M-M-R II Consistency Study in Healthy Children
NCT01702428Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 3 trial of measles, mumps and rubella vaccine (live) in measles, mumps, rubella, sponsored by GSK. Started Nov 2012; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT01702428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702428.